PHK
MRSN

Point72 Hong Kong’s Mersana Therapeutics MRSN Stock Holding History

Point72 Hong Kong’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-606
Closed -$102K – 1121
2022
Q3 		$102K Buy
+606
New +$98.5K 0.01% 1227
2022
Q2 		– Sell
-571
Closed -$57K – 2254
2022
Q1 		$57K Buy
571
+204
+56% +$23.8K 0.01% 1305
2021
Q4 		$57K Buy
+367
New +$71.4K ﹤0.01% 1307
2021
Q3 		– Sell
-354
Closed -$120K – 2297
2021
Q2 		$120K Buy
354
+243
+219% +$92K 0.01% 1278
2021
Q1 		$45K Buy
+111
New +$53.8K ﹤0.01% 1304
2020
Q3 		– Sell
-238
Closed -$139K – 1402
2020
Q2 		$139K Buy
+238
New +$81.3K 0.02% 571
2019
Q4 		– Sell
-41
Closed -$2K – 1348
2019
Q3 		$2K Buy
+41
New +$2.98K ﹤0.01% 874
2019
Q2 		– Sell
-28
Closed -$4K – 1297
2019
Q1 		$4K Buy
+28
New +$3.52K ﹤0.01% 837
2018
Q3 		– Sell
-27
Closed -$12K – 1080
2018
Q2 		$12K Buy
+27
New +$11.9K ﹤0.01% 640

Other funds holding MRSN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return